BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 847 filers reported holding BAXTER INTL INC in Q2 2013. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $258,646,939 | -17.2% | 6,853,390 | 0.0% | 0.26% | -15.3% |
Q2 2023 | $312,240,448 | +12.3% | 6,853,390 | 0.0% | 0.31% | +6.6% |
Q1 2023 | $277,973,498 | -20.4% | 6,853,390 | 0.0% | 0.29% | -21.1% |
Q4 2022 | $349,317,288 | -5.4% | 6,853,390 | 0.0% | 0.36% | -17.8% |
Q3 2022 | $369,124,000 | -16.1% | 6,853,390 | 0.0% | 0.44% | -11.7% |
Q2 2022 | $440,193,000 | -17.2% | 6,853,390 | 0.0% | 0.50% | -5.8% |
Q1 2022 | $531,412,000 | -9.7% | 6,853,390 | 0.0% | 0.53% | -8.4% |
Q4 2021 | $588,295,000 | +6.7% | 6,853,390 | 0.0% | 0.58% | -4.9% |
Q3 2021 | $551,218,000 | -0.1% | 6,853,390 | 0.0% | 0.61% | +10.8% |
Q2 2021 | $551,698,000 | -4.6% | 6,853,390 | 0.0% | 0.55% | -9.6% |
Q1 2021 | $578,015,000 | +5.1% | 6,853,390 | 0.0% | 0.61% | -2.9% |
Q4 2020 | $549,916,000 | -0.2% | 6,853,390 | 0.0% | 0.63% | -10.5% |
Q3 2020 | $551,150,000 | -6.6% | 6,853,390 | 0.0% | 0.70% | -13.2% |
Q2 2020 | $590,077,000 | +6.0% | 6,853,390 | 0.0% | 0.81% | -8.2% |
Q1 2020 | $556,427,000 | -2.9% | 6,853,390 | 0.0% | 0.88% | +22.5% |
Q4 2019 | $573,080,000 | -4.4% | 6,853,390 | 0.0% | 0.72% | -2.6% |
Q3 2019 | $599,466,000 | +6.8% | 6,853,390 | 0.0% | 0.74% | +6.5% |
Q2 2019 | $561,293,000 | +0.7% | 6,853,390 | 0.0% | 0.70% | -2.3% |
Q1 2019 | $557,249,000 | +23.5% | 6,853,390 | 0.0% | 0.71% | +11.1% |
Q4 2018 | $451,090,000 | -14.6% | 6,853,390 | 0.0% | 0.64% | -3.2% |
Q3 2018 | $528,328,000 | +4.4% | 6,853,390 | 0.0% | 0.66% | -2.4% |
Q2 2018 | $506,054,000 | +13.5% | 6,853,390 | 0.0% | 0.68% | +12.5% |
Q1 2018 | $445,745,000 | -45.8% | 6,853,390 | -46.1% | 0.60% | -41.8% |
Q4 2017 | $822,595,000 | +3.0% | 12,725,794 | 0.0% | 1.03% | -3.4% |
Q3 2017 | $798,543,000 | +3.7% | 12,725,794 | 0.0% | 1.07% | +0.8% |
Q2 2017 | $770,419,000 | +16.7% | 12,725,794 | 0.0% | 1.06% | +14.8% |
Q1 2017 | $659,959,000 | +17.0% | 12,725,794 | 0.0% | 0.92% | +15.0% |
Q4 2016 | $564,262,000 | -6.8% | 12,725,794 | 0.0% | 0.80% | -10.7% |
Q3 2016 | $605,748,000 | +5.3% | 12,725,794 | 0.0% | 0.90% | +3.8% |
Q2 2016 | $575,460,000 | +10.1% | 12,725,794 | 0.0% | 0.87% | +5.5% |
Q1 2016 | $522,776,000 | +7.7% | 12,725,794 | 0.0% | 0.82% | +4.6% |
Q4 2015 | $485,490,000 | +16.1% | 12,725,794 | 0.0% | 0.79% | +12.0% |
Q3 2015 | $418,042,000 | -53.0% | 12,725,794 | 0.0% | 0.70% | -48.2% |
Q2 2015 | $889,914,000 | -1.6% | 12,725,794 | -3.6% | 1.36% | +0.4% |
Q1 2015 | $903,967,000 | -6.5% | 13,196,594 | 0.0% | 1.35% | -3.7% |
Q4 2014 | $967,179,000 | +2.1% | 13,196,594 | 0.0% | 1.40% | 0.0% |
Q3 2014 | $947,120,000 | -1.1% | 13,196,594 | -0.3% | 1.40% | -1.9% |
Q2 2014 | $957,267,000 | -1.7% | 13,240,194 | 0.0% | 1.43% | -5.6% |
Q1 2014 | $974,214,000 | +5.8% | 13,240,194 | 0.0% | 1.51% | +3.1% |
Q4 2013 | $920,856,000 | +5.9% | 13,240,194 | 0.0% | 1.47% | -4.0% |
Q3 2013 | $869,749,000 | -5.2% | 13,240,194 | 0.0% | 1.53% | -8.2% |
Q2 2013 | $917,149,000 | – | 13,240,194 | – | 1.67% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |